Innovative System Provides Extremely Precise, Non-invasive Treatment in Four to Five Sessions SUNNYVALE, Calif. , Oct. 13, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Anova Cancer Care in Denver, Colorado , has treated its 1,000th prostate cancer patient with the
SUNNYVALE, Calif. , Oct. 8, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal first quarter ended September 30, 2015 on October 29, 2015 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m.
RayStation® will be Extended to Include Treatment Planning for the TomoTherapy® and CyberKnife® Systems SUNNYVALE, Calif. , and STOCKHOLM , Oct. 5, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) and RaySearch Laboratories AB (publ) (NASDAQ OMX Stockholm: RAY B) announced today that they
Succeeds Retiring CFO Greg Lichtwardt SUNNYVALE, Calif. , Sept. 15, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Kevin Waters , formerly Senior Vice President, Finance, has been promoted to Chief Financial Officer of the Company effective as of today. He
SUNNYVALE, Calif. , Sept. 1, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that its management team is scheduled to present at the Morgan Stanley Global Healthcare Conference 2015 in New York, NY on Thursday, September 17, 2015 at 12:55pm ET . A live webcast of the
SUNNYVALE, Calif. , Aug. 21, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has received a multi-system order from 21 st Century Oncology for one CyberKnife ® M6™ and four TomoHDA™ Systems. These are the latest generation CyberKnife and TomoTherapy Systems, and are
Reports Financial Results for Fourth Quarter and Fiscal 2015, Introduces Fiscal 2016 Guidance SUNNYVALE, Calif. , Aug. 20, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the fiscal fourth quarter and fiscal year ended June 30, 2015 .
SUNNYVALE, Calif. , Aug. 3, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal fourth quarter and full year ended June 30, 2015 on August 20, 2015 after the market close. Management will host a conference call to review the results at 1:30 p.m.
User Satisfaction Ratings Consistently Exceeded Industry Average for the Past Two Years SUNNYVALE, Calif. , July 27, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its CyberKnife ® and TomoTherapy ® Systems have received the highest composite overall user
Studies of the InCise™ Multileaf Collimator (MLC) for the CyberKnife M6™ System Reinforce its Accuracy, Reliability and Precise Dose Delivery SUNNYVALE, Calif. , July 14, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that studies on the clinical use of the CyberKnife ®
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
